EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic Potential of Spermidine in Rheumatoid Arthritis: Mechanisms and Future Directions

Yi Chen iD, Yi-Feng Zhou, Zhen-Yi Long, Ya-Meng Peng, Si-Xian Wu, Fang Peng, Ming-Hao Yuan, Yi-Zhao Zhou iD, Lei Wang, Hao Yuan iD

International Journal of Rheumatic Diseases · 2026-03 · 29 (3)

DOI: 10.1111/1756-185x.70610 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 20.03.2026. Verfasst von Yi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Hunan Provincial People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Spermidine, Antirheumatic Agents, Joints. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: the Key Project of Hunan Provincial Health Commission, the Key Cultivation Project of Renshu Fund of Hunan Provincial People's Hospital, the Natural Science Foundation of Changsha Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disease that not only severely impairs joint function but also leads to various systemic complications, significantly reducing patients' quality of life. Furthermore, RA imposes a substantial economic burden on healthcare systems globally. Current clinical treatments primarily consist of non‐steroidal anti‐inflammatory drugs, glucocorticoids, and disease‐modifying antirheumatic drugs, which effectively control symptoms and delay joint damage. However, achieving a complete cure remains a considerable challenge. Consequently, therapeutic strategies aimed at joint protection and the prevention of systemic complications have become central to research efforts. Spermidine (SPD), a naturally occurring polyamine in the human body, has garnered significant attention due to its multifaceted effects as anti‐aging, cardiovascular protection, neuroregulation, and anti‐inflammation. Notably, SPD has shown significant therapeutic effects in mouse models of various inflammatory diseases, including inflammatory bowel disease, psoriasis, osteoarthritis and RA. The exploration of the role of SPD in RA may provide new targets and effective therapeutic approaches for the treatment of RA. This review provided a comprehensive overview of the potential mechanisms of SPD in the pathological progression of RA, including the inhibition of inflammatory cytokines expression, reduction of oxidative stress, modulation of immune cell functions, and maintenance of bone metabolism homeostasis. Through these mechanisms, SPD shows potential as a promising novel candidate for RA therapy. However, its precise efficacy and safety must be validated through large‐scale clinical trials. This article aimed to provide theoretical insights and future research directions for understanding the pathological mechanisms of RA and developing novel therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSpermidineAntirheumatic AgentsJointsHumansAnimalsInflammation MediatorsOxidative StressSignal TransductionCytokinesTreatment Outcome

Stichwörter der Autor:innen

immune cellsinflammatory cytokinesosteoblastsosteoclastsoxidative stressrheumatoid arthritisspermidine

Substanzen

SpermidineInflammation MediatorsAntirheumatic AgentsCytokines

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Hunan Provincial People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Department of Operating, Hunan Provincial People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Department of Orthopedics, Hunan Provincial People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Big Data Innovation and Entrepreneurship Education Center of Hunan Province, Changsha University, Changsha, China.

ORCID-Profile: Yi Chen, Yi-Zhao Zhou, Hao Yuan

Förderung

  • the Key Project of Hunan Provincial Health Commission
  • the Key Cultivation Project of Renshu Fund of Hunan Provincial People's Hospital
  • the Natural Science Foundation of Changsha Science and Technology Bureau
  • the Natural Science Foundation of Hunan Provincial Department of Science and Technology

Zitieren

APA

Chen, Y., Zhou, Y. F., Long, Z. Y., Peng, Y. M., Wu, S. X., Peng, F., Yuan, M. H., Zhou, Y. Z., Wang, L., & Yuan, H. (2026). Therapeutic Potential of Spermidine in Rheumatoid Arthritis: Mechanisms and Future Directions. International Journal of Rheumatic Diseases, 29(3). https://doi.org/10.1111/1756-185x.70610

Vancouver

Chen Y, Zhou YF, Long ZY, Peng YM, Wu SX, Peng F, et al. Therapeutic Potential of Spermidine in Rheumatoid Arthritis: Mechanisms and Future Directions. International Journal of Rheumatic Diseases. 2026;29(3). doi:10.1111/1756-185x.70610

BibTeX
@article{Chen2026,
  author = {Chen, Yi and Zhou, Yi-Feng and Long, Zhen-Yi and Peng, Ya-Meng and Wu, Si-Xian and Peng, Fang and Yuan, Ming-Hao and Zhou, Yi-Zhao and Wang, Lei and Yuan, Hao},
  title = {Therapeutic Potential of Spermidine in Rheumatoid Arthritis: Mechanisms and Future Directions},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {3},
  doi = {10.1111/1756-185x.70610}
}
Kostenlos starten →